¼¼°èÀÇ ¿£µµÅå½Å °Ë»ç ½ÃÀå º¸°í¼­(2025³â)
Endotoxin Testing Global Market Report 2025
»óǰÄÚµå : 1686325
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 200 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,324,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,141,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,958,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¿£µµÅå½Å °Ë»ç ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¼ö³â°£ °­·ÂÇÑ ¼ºÀåÀ» ÀÌ·ê °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù. ¿¹Ãø ±â°£ÀÇ ¼ºÀåÀº ¹ÙÀÌ¿À Á¦¾à »ê¾÷ÀÇ È®Àå, ³»µ¶¼Ò °Ë»ç ¿¬±¸ ¹× °³¹ß¿¡ ´ëÇÑ ÅõÀÚ Áõ°¡, ±Û·Î¹ú ÀÇ·á È®Àå¿¡ ±âÀÎ ÇÒ ¼ö ÀÖ½À´Ï´Ù.

ÀÇ·á °ü·Ã °¨¿°ÀÇ ¹ß»ý·ü Áõ°¡´Â ¿£µµÅå½Å °Ë»ç ½ÃÀå È®´ëÀÇ Áß¿äÇÑ ÃËÁø¿äÀÎÀÌ µÉ °ÍÀ¸·Î »ý°¢µÇ°í ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ °¨¿°Àº Á¾Á¾ ¿À¿°µÈ ÀÇ·á Àåºñ³ª ½Ã¼ú·Î ÀÎÇØ ¹ß»ýÇϱ⠶§¹®¿¡ ȯÀÚ ¾ÈÀüÀ» º¸ÀåÇϱâ À§ÇØ Ã¶ÀúÇÑ °Ë»ç°¡ ÇÊ¿äÇÔÀ» °­Á¶ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2022³â 12¿ù ±âÁØ À¯¿£ ±¹Á¦ ¾Æµ¿ ±ä±Þ ±â±Ý(UNICEF)ÀÇ º¸°í¿¡ µû¸£¸é, Æó·ÅÀº °¡Àå ¸¹Àº ¾ÆÀ̵éÀÇ »ý¸íÀ» »©¾ÑÀº °¨¿°ÁõÀ¸·Î, ¿¬°£ 70¸¸¸í ÀÌ»ó, ÇÏ·ç¿¡ ¾à 2,000¸íÀÇ ¾ÆÀ̵éÀÌ »ç¸ÁÇß½À´Ï´Ù. ¶ÇÇÑ ¼¼°èº¸°Ç±â±¸ÀÇ 2022³â 5¿ù µ¥ÀÌÅÍ¿¡ µû¸£¸é ¸Å³â ¾à 24%ÀÇ È¯ÀÚ°¡ ÀÇ·á °ü·Ã ÆÐÇ÷Áõ¿¡ °É¸®¸ç, ÁßȯÀڽǿ¡¼­ Ä¡·á¹Þ´Â ȯÀÚÀÇ »ç¸Á·üÀº ¿¬°£ 52.3%¿¡ ´ÞÇÕ´Ï´Ù.

´Ù¾çÇÑ °Ë»ç¸¦ ½Ç½ÃÇϱâ À§ÇÑ »ý¹°Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡´Â ¿£µµÅå½Å °Ë»ç ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. 2022³â 5¿ù, European Pharmaceutical Review(EPR)´Â »ý¹° Á¦Á¦°¡ ÇâÈÄ 5³â°£ Çõ½ÅÀûÀÎ ÀúºÐÀÚ ¸ÅÃâÀ» Å©°Ô ¿ôµ¹¾Æ 2027³â±îÁö 1,200¾ï ´Þ·¯ÀÇ ¸ÅÃâ Áõ°¡°¡ Àü¸ÁµÉ °ÍÀ¸·Î º¸°íÇß½À´Ï´Ù. ±× °á°ú, ´Ù¾çÇÑ °Ë»ç¸¦ ½Ç½ÃÇϱâ À§ÇÑ »ý¹° Á¦Á¦¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡°¡ ¿£µµÅå½Å °Ë»ç ½ÃÀåÀÇ È®´ë¸¦ µÞ¹ÞħÇϰí ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, Äڷγª, ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ ÇÁ·ÎÆÄÀÏ

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀåÀÇ ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

KTH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Endotoxin testing, also known as the bacterial endotoxins test (BET), is a laboratory-based assay designed to evaluate the levels of bacterial endotoxins in substances, with a particular focus on pharmaceuticals and medical devices. The primary goal of this testing is to ensure product safety and compliance with stringent quality standards, thereby reducing the risk of potential adverse effects on patients and users.

Endotoxin testing encompasses various methods, including LAL (limulus amebocyte lysate) tests, chromogenic tests, turbidimetric tests, gel clot tests, MAT tests, rabbit pyrogen tests, and recombinant factor C (rFC) assays. Among these, the LAL test stands out as a highly sensitive assay employed to detect bacterial endotoxins in medical and pharmaceutical products. This method leverages the clotting response of horseshoe crab blood components to identify the presence of endotoxins. The LAL test is applicable in diverse areas, such as medical devices, pharmaceuticals, packaging, and raw materials, and is utilized by various end-users, including hospitals, laboratories, and research institutes.

The endotoxin testing market research report is one of a series of new reports from The Business Research Company that provides endotoxin testing market statistics, including endotoxin testing industry global market size, regional shares, competitors with an endotoxin testing market share, detailed endotoxin testing market segments, market trends and opportunities and any further data you may need to thrive in the endotoxin testing industry. This endotoxin testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endotoxin testing market size has grown steadily in recent years. It will grow from $2.24 billion in 2024 to $2.32 billion in 2025 at a compound annual growth rate (CAGR) of 3.6%. The growth in the historic period can be attributed to increasing demand for biologics and biosimilars, growing awareness about the importance of endotoxin testing, growing prevalence of infectious diseases.

The endotoxin testing market size is expected to see strong growth in the next few years. It will grow to $2.91 billion in 2029 at a compound annual growth rate (CAGR) of 5.8%. The growth in the forecast period can be attributed to expansion of the biopharmaceutical industry, increasing investment in research and development of endotoxin testing, global healthcare expansion. Major trends in the forecast period include innovative endotoxin detection tools, adoption of endotoxin testing service, demand for endotoxin testing services.

The growing incidence of healthcare-associated infections is poised to be a significant driver for the expansion of the endotoxin testing market. Healthcare-associated infections pertain to infections that individuals acquire while receiving medical treatment and were not present at the time of their admission to a healthcare facility. These infections often result from contaminated medical equipment or procedures, emphasizing the need for thorough testing to ensure patient safety. Endotoxin testing services play a vital role in preventing healthcare-associated infections by evaluating bacterial endotoxin levels in various medical equipment, particularly in injectable pharmaceutical products and implantable medical devices. For instance, as of December 2022, reports from the United Nations International Children's Emergency Fund (UNICEF) indicated that pneumonia was the infectious disease claiming the most children's lives, causing over 700,000 annual fatalities, which equates to approximately 2,000 children per day. Moreover, according to the World Health Organization's data from May 2022, approximately 24% of patients are affected by healthcare-associated sepsis each year, and the mortality rate for patients treated in intensive care units is as high as 52.3% annually. Consequently, the increasing prevalence of healthcare-associated infections is a major driving force behind the growth of the endotoxin testing market.

The increasing demand for biologics to conduct various tests is expected to drive the growth of the endotoxin testing market. Biologics, also referred to as biopharmaceuticals, are pharmaceuticals developed using living organisms, cells, or biological processes. Endotoxin testing is critical for biologics to ensure their safety, quality, and compliance with regulatory standards. For example, in May 2022, the European Pharmaceutical Review (EPR), a UK-based non-governmental organization, reported that biologics are projected to significantly surpass sales of innovative small molecules in the next five years, with an expected $120 billion increase in sales by 2027. This signifies a notable shift in the pharmaceutical market toward biologic products. As a result, the growing demand for biologics to conduct various tests is driving the expansion of the endotoxin testing market.

Key players in the endotoxin testing market are dedicated to embracing cutting-edge technological solutions to maintain their market standing. As an example, in August 2023, Lonza Group AG, a Switzerland-based pharmaceutical, biotechnology, and nutrition manufacturing company, introduced the Nebula absorbance reader, a novel absorbance microplate reader designed to streamline endotoxin and pyrogen testing. This instrument seamlessly integrates with Lonza's latest WinKQCL software to enhance data integrity compliance, expedite training, and reduce validation requirements. Users of WinKQCL software are no longer burdened with the need to learn new software to utilize this state-of-the-art reader, resulting in reduced training efforts. The Nebula Absorbance Reader is a forward-thinking and technologically advanced replacement reader that yields results akin to those frequently obtained with the ELx808, the industry-standard absorbance reader that Lonza no longer offers for sale. Furthermore, it is designed to be fully compatible with and meet the stringent requirements of Lonza's absorbance-based endotoxin assays, including the Lonza PYROGENT 5000 Turbidimetric and Kinetic-QCL Chromogenic Endotoxin Assays.

In January 2022, Suez Water Technologies and Solutions, a prominent water treatment company based in the United States, completed the acquisition of Sentinel Monitoring Systems Inc. for an undisclosed sum. This strategic acquisition serves to enhance Veolia Water Technologies & Solutions' analytical instrument line while unlocking new opportunities in the microbiological monitoring market. Sentinel Monitoring Systems Inc., a US-based company, specializes in the development of online bioburden monitoring tools and instrument platforms designed for endotoxin testing.

Major companies operating in the endotoxin testing market are Thermo Fisher Scientific Inc., Merck KGaA, bioMerieux SA., Eurofins Scientific SE, Lonza Group Ltd., WuXi AppTec Co. Ltd., Bio-Rad Laboratories Inc., Maravai LifeSciences Holdings Inc., Cambrex Corporation, GenScript Biotech Corporation, Charles River Laboratories International Inc., Nelson Laboratories LLC, Lifecore Biomedical Inc., Stellar Biotechnologies Inc., Biovision Inc., Associates of Cape Cod Inc., FUJIFILM Wako Pure Chemical Corporation, InvivoGen Inc., Tebu-bio Nv., MatTek Corporation, Microcoat Biotechnologie GmbH, Accelagen Inc., BioAssay Systems LLC, BioThema AB, Hycult Biotech Inc., Pacific Biolabs Inc., Xiamen Bioendo Technology Co. Ltd., Zhanjiang A&C Biological Ltd., Accugen Laboratories Inc.

North America was the largest region in the endotoxin testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in endotoxin testing report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the endotoxin testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endotoxin testing market consists of revenues earned by entities by providing contract testing services, ecologically sustainable testing and rapid testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endotoxin testing market also includes sales of injectable pharmaceutical products, endotoxin detection systems, limulus amebocyte lysate test reagents and polymerase chain reaction mycoplasma detection kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endotoxin Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endotoxin testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for endotoxin testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endotoxin testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. Endotoxin Testing Market Characteristics

3. Endotoxin Testing Market Trends And Strategies

4. Endotoxin Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Endotoxin Testing Growth Analysis And Strategic Analysis Framework

6. Endotoxin Testing Market Segmentation

7. Endotoxin Testing Market Regional And Country Analysis

8. Asia-Pacific Endotoxin Testing Market

9. China Endotoxin Testing Market

10. India Endotoxin Testing Market

11. Japan Endotoxin Testing Market

12. Australia Endotoxin Testing Market

13. Indonesia Endotoxin Testing Market

14. South Korea Endotoxin Testing Market

15. Western Europe Endotoxin Testing Market

16. UK Endotoxin Testing Market

17. Germany Endotoxin Testing Market

18. France Endotoxin Testing Market

19. Italy Endotoxin Testing Market

20. Spain Endotoxin Testing Market

21. Eastern Europe Endotoxin Testing Market

22. Russia Endotoxin Testing Market

23. North America Endotoxin Testing Market

24. USA Endotoxin Testing Market

25. Canada Endotoxin Testing Market

26. South America Endotoxin Testing Market

27. Brazil Endotoxin Testing Market

28. Middle East Endotoxin Testing Market

29. Africa Endotoxin Testing Market

30. Endotoxin Testing Market Competitive Landscape And Company Profiles

31. Endotoxin Testing Market Other Major And Innovative Companies

32. Global Endotoxin Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endotoxin Testing Market

34. Recent Developments In The Endotoxin Testing Market

35. Endotoxin Testing Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â